Adagio Medical Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADGM research report →
Range $3 – $3
Price Chart
About the company
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia.
- CEO
- Todd Usen
- IPO
- 2024
- Employees
- 41
- HQ
- Laguna Hills, CA, US
Get TickerSpark's AI analysis on ADGM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.07M
- P/E
- -0.10
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -7.39
- EV/EBITDA
- -0.92
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -661.85%
- ROIC
- -74.66%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-684,000+59.0%
- Op Income
- $-21,890,000
- Net Income
- $-25,084,000+53.3%
- EPS
- $-1.51+57.3%
- OCF Growth
- +35.5%
- FCF Growth
- +37.7%
- 52W High
- $2.58
- 52W Low
- $0.12
- 50D MA
- $0.50
- 200D MA
- $0.84
- Beta
- -0.19
- RSI (14)
- 22
- Avg Volume
- 9.15M
No earnings-call transcripts are available for ADGM yet.
- Free Float
- 98.2%
- Shares Outstanding
- 22.21M
- Float Shares
- 21.80M
of shares held by institutions
23 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Perceptive Advisors LLC | 9.88M | ▲ 10 |
| Adage Capital Partners Gp, L.L.C. | 1.26M | 0 |
| Adar1 Capital Management, LLC | 1.21M | 0 |
| Alyeska Investment Group, L.P. | 1.16M | 0 |
| Sio Capital Management, LLC | 698.99K | ▼ 589.47K |
| Silverarc Capital Management, LLC | 224.36K | ▼ 27.61K |
| Shaolin Capital Management LLC | 171.17K | 0 |
| Vanguard Capital Management LLC | 108.95K | ▲ 69.35K |
| Affinity Asset Advisors, LLC | 80.00K | 0 |
| Vanguard Group Inc | 79.45K | ▲ 46.37K |
| Geode Capital Management, LLC | 79.11K | ▼ 46.13K |
| Vanguard Fiduciary Trust Co | 53.78K | 0 |
Held by 18 ETFs
Biggest fund positions in ADGM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | Salmon Sean | other | 30,000 |
| Jun 16, 26 | Mirsaeedi-Farahani Keyvan | other | 30,000 |
| Jun 16, 26 | Cox James L | other | 30,000 |
| Jun 16, 26 | GARDINER SANDRA A. | other | 30,000 |
| Jun 16, 26 | MISHAN ORLY | other | 100,000 |
| Jun 16, 26 | Moran Timothy P. | other | 30,000 |
| Mar 6, 26 | Kaster Deborah | other | 490,500 |
| Mar 6, 26 | Usen Todd | other | 800,000 |
| Dec 16, 25 | Kaster Deborah | buy | 15,000 |
| Dec 12, 25 | Usen Todd | buy | 207,315 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ADGM coverage
Recent articles, reports, and earnings notes.
No research on ADGM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADGM report →Adagio Medical Holdings, Inc. (NASDAQ:ADGM) Sees Significant Growth in Short Interest
defenseworld.net · Oct 1
Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
businesswire.com · Sep 23
Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner -- University Medical Center Phoenix
gurufocus.com · Sep 16
Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix
businesswire.com · Sep 16
Adagio Medical Reports Second Quarter 2026 Results
businesswire.com · Aug 11
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
businesswire.com · Aug 3
Robo.ai Announces Core Executive Appointments, Forming a Local UAE Leadership Team at Neurovia AI
gurufocus.com · Jul 14
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
businesswire.com · May 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.